Rapid generation of durable B cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 and convalescence

Hartley, Gemma E., Edwards, Emily S.J., Aui, Pei M., Varese, Nirupama, Stojanovic, Stephanie, McMahon, James, Peleg, Anton Y., Boo, Irene +4 more·2020·Science Immunology
DOI 10.1126/sciimmunol.abf8891

Cited by (295)

Items 201–295 of 295

  1. Impact of SARS-CoV-2 Infection and Vaccination on Pregnancy Outcome and Passive Neonatal Immunity
    Gina Marie Uehre, Valeriia Grabar, Evelin Grage‐Griebenow, Oliver Klemens, Laura Scholz, Nils Hoymann, Suzan Alboradi, Atanas Ignatov, Svetlana N. Tchaikovski, Mandy Busse · 2025 · Cells
  2. COVID-19 after rituximab therapy in cSLE patients
    Meghan Corrigan Nelson, Cynthia K. Manos, Elaine Flanagan, Sampath Prahalad · 2023 · Therapeutic Advances in Vaccines and Immunotherapy
  3. Time course and determinants of the antibody response to SARS-CoV-2 in Costa Rica: the RESPIRA study
    Rolando Herrero, Romain Fantin, Viviana Loría, Amada Aparicio, D. Rebecca Prevots, Michael Zúñiga, Roy Wong, Melvin Morera, Julia Butt, Marco Binder et al. · 2025 · BMC Infectious Diseases
  4. SARS-CoV-2 Neutralizing Responses in Various Populations, at the Time of SARS-CoV-2 Variant Virus Emergence: Evaluation of Two Surrogate Neutralization Assays in Front of Whole Virus Neutralization Test
    Stéphane Marot, Djeneba Fofana, Philippe Flandre, Isabelle Malet, Karen Zafilaza, Valentin Leducq, Diane Vivien, Sarah Mrabet, Corentin Poignon, Vincent Cálvez et al. · 2022 · Life
  5. The race to understand immunopathology in COVID-19: Perspectives on the impact of quantitative approaches to understand within-host interactions
    Sonia Gazeau, Xiaoyan Deng, Hsu Kiang Ooi, Fatima Mostefai, Julie Hussin, Jane Marie Heffernan, Adrianne L. Jenner, Morgan Craig · 2023 · ImmunoInformatics
  6. Evaluation of the Humoral and Cellular Immune Response Post COVID-19 Infection in Kidney Transplant Recipients
    Kahina Bensaid, Lydia Lamara Mahammed, Khadidja Habchi, Messaoud Saidani, Ines Allam, Réda Djidjik · 2023 · Journal of Clinical Medicine
  7. Immunogenicity and Protective Efficacy of Psoralen-Inactivated SARS-CoV-2 Vaccine in Nonhuman Primates
    John W. Sanders, Daniel F. Ewing, Appavu K. Sundaram, Christopher S. Gamble, Maria W. Blevins, Zhaodong Liang, Leigh Ann Sanders, David A. Ornelles, Peifang Sun, Klara Lenart et al. · 2024 · Vaccines
  8. Vaccine or monoclonal therapy: which is the winning weapon against COVID-19?
    Lorenzo Lo Muzio, Maria Eleonora Bizzoca · 2021 · Journal of Global Antimicrobial Resistance
  9. SARS-CoV-2 and regular patient treatment – from the use of rapid antigen testing up to treatment specific precaution measures
    Jürgen Durner, Thomas Beikler, David Christopher Watts, Marc Becker, Miriam Esther Draenert · 2021 · Head & Face Medicine
  10. Validation of conventional PCR-like alternative to SARS-CoV-2 detection with target nucleocapsid protein gene in naso-oropharyngeal samples
    Rogério Fernandes Carvalho, Monike da Silva Oliveira, Juliane Ribeiro, Isac Gabriel Cunha dos Santos, Katyane de Sousa Almeida, Ana Carolina Müller Conti, Bruna Alexandrino, Fabrício Souza Campos, Célia Maria de Almeida Soares, José Carlos Ribeiro Júnior · 2021 · PLoS ONE
  11. Impact of Host Immune Status on Discordant Anti-SARS-CoV-2 Circulating B Cell Frequencies and Antibody Levels
    Frédéric Coutant, Jean‐Jacques Pin, Florence Morfin, Tristan Ferry, Stéphane Paul, Bruno Pozzetto, Myriam Normand, Pierre Miossec · 2021 · International Journal of Molecular Sciences
  12. SARS-CoV-2 Viral Incidence, Antibody Point Prevalence, Associated Population Characteristics, and Vaccine Attitudes, South Carolina, February 2021
    Melissa S. Nolan, Virginie Daguisé, Megan Davis, Joan M. Duwve, Windsor Westbrook Sherrill, Moonseong Heo, Alain H. Litwin, Mufaro Kanyangarara, Stella Coker Watson Self, Rongjie Huang et al. · 2022 · Public Health Reports
  13. Impaired Cellular and Antibody immunity after COVID-19 in Chronically Immunosuppressed Transplant Recipients
    Chethan Ashokkumar, Vinayak Rohan, Alexander Kroemer · 2023 · Journal of Surgery and Research
  14. Severe Acute Respiratory Syndrome Coronavirus 2 Diagnostic Tests for Border Screening During the Very Early Phase of Coronavirus Disease 2019 Pandemic: A Systematic Review and Meta-Analysis
    Pearleen Ee Yong Chua, Sylvia Xiao Wei Gwee, Min Xian Wang, Hao Gui, Junxiong Pang · 2022 · Frontiers in Medicine
  15. Longitudinal monitoring of SARS-CoV-2 spike protein-specific antibody responses in Lower Austria
    Heike Rebholz, Ralf J. Braun, Titas Saha, Oliver Harzer, Miriam Schneider, Dennis Ladage · 2022 · PLoS ONE
  16. Cohort Profile: Immune Responses to SARS-COV-2 Vaccination and Infection in a Longitudinal Sampling Amidst the COVID-19 Pandemic (LONGTONG-SARS2) in Malaysia
    Naim Che-Kamaruddin, Jefree Johari, Hasmawati Yahaya, Huy C Nguyen, Andrew G. Letizia, Robert D. Hontz, Sazaly AbuBakar · 2024 · medRxiv
  17. Anti-SARS-Cov-2 S-RBD IgG Formed after BNT162b2 Vaccination Can Bind C1q and Activate Complement
    Anas H. A. Abu-Humaidan, Fatima M. Ahmad, Dima Awajan, Raba’a F. Jarrar, Nader Alaridah · 2022 · Journal of Immunology Research
  18. Raman spectroscopic analysis of human serum samples of convalescing COVID-19 positive patients
    Naomi Jackson, Jaythoon Hassan, Hugh James Byrne · 2023 · Clinical Spectroscopy
  19. Modelling and investigating memory immune responses in infectious disease. Application to influenza a virus and sars-cov-2 reinfections
    Mathilde Massard, Bruno Saussereau, Catherine Chirouze, Quentin Lepiller, Raluca Eftimie, Antoine Perasso · 2024 · Infectious Disease Modelling
  20. Systemic inflammation is associated with worse outcomes from SARS-CoV-2 infection but not neutralizing antibody
    Christopher W. Farnsworth, B. Roemmich, J. Prostko, G. Davis, G. Murtagh, L. Jackson, C. Jacobson, N. Jeanblanc, T. Griffiths, E. Frias et al. · 2025 · Microbiology spectrum
  21. Survival after primary and booster COVID-19 vaccination in patients with COPD
    Sevim Selen Karabulut, Aslı Nemli, Yalçın Koçyiğit · 2025 · Clinical and Experimental Vaccine Research
  22. SARS-CoV-2 Serology Monitoring of a Cancer Center Staff in the Pandemic Most Infected Italian Region
    Chiara Maura Ciniselli, Arianna Micali, Loris De Cecco, Paola Notti, Valentina Sinno, Elena Luison, Cecilia C. Melani, Maria Grazia Daidone, Giovanni Apolone, Paolo Verderio et al. · 2021 · Cancers
  23. The benefit of boosters: diversity and inclusion in the COVID‐19 memory response
    Gemma E. Hartley, Menno C. van Zelm, Marcus J Robinson · 2021 · Immunology and Cell Biology
  24. Magnetic Enrichment of SARS-CoV-2 Antigen-Binding B Cells for Analysis of Transcriptome and Antibody Repertoire
    Maureen Banach, Isaac T. W. Harley, Mary K. McCarthy, Cody Rester, Adonis Stassinopoulos, Ross M. Kedl, Thomas E. Morrison, John C. Cambier · 2022 · Magnetochemistry
  25. Analysis of Clinical Course and Vaccination Influence on Serological Response in COVID-19 Convalescents
    Justyna Adamczuk, Piotr Czupryna, Justyna Dunaj, Ewelina Kruszewska, Sławomir Andrzej Pancewicz, Karol Adam Kamiński, Karol Borawski, Sambor Grygorczuk, Anna M. Moniuszko-Malinowska · 2022 · Microbiology Spectrum
  26. Dynamics of SARS-CoV-2-Specific B Cell Memory Responses in Infected and Vaccinated Individuals
    Marco Fabiani, Katia Margiotti, Francesca Monaco, Antonella Viola, Antonella Cima, Alvaro Mesoraca, Claudio Giorlandino · 2023 · Viral Immunology
  27. Effects of strict public health measures on seroprevalence of anti–SARS-CoV-2 antibodies during pregnancy
    Hillary H. Y. Leung, Christy YT Kwok, Daljit Singh Sahota, Bo Wah Leung, Grace Chung-Yan Lui, Susanna S. Ng, WC Leung, Paul K.S. Chan, Liona C. Poon · 2022 · Hong Kong Medical Journal
  28. COVID ‐19 Alpha Variant (B.1.1.7): Humoral, memory B and T cells in COVID ‐19 pediatric convalescents
    Michael Gurevich, Rina Zilkha‐Falb, Polina Sonis, David Magalashvili, Mark Dolev, Mathilda Mandel, Shay Menascu, Anat Achiron · 2022 · Pediatric Allergy and Immunology
  29. The Influence of Booster Shot and SARS-CoV-2 Infection on the Anti-Spike Antibody Concentration One Year after the First COVID-19 Vaccine Dose Administration
    Jakub Swadźba, Tomasz Anyszek, Andrzej Panek, Agnieszka Chojęta, Anna Piotrowska-Mietelska, Emilia Martin · 2023 · Vaccines
  30. TAK1 is essential for MAIT cell development and the differentiation of MAIT1 and MAIT17
    Rachel Krevh, Jie Wang, Bobby Zuniga, Jugmohit S. Toor, Kalpana Subedi, Zhou Li, Qing‐Sheng Mi · 2023 · Cellular and Molecular Immunology
  31. Neutralizing antibody responses 10 months after mild and moderately-severe SARS-CoV-2 infection
    Puya Dehgani‐Mobaraki, Asiya Kamber Zaidi, Annamaria Porreca, A. Floridi, Emanuela Floridi · 2021 · medRxiv
  32. Categorizing the Status of COVID-19 Outbreaks Around the World
    J. Paul Callan, Carlijn J.A. Nouwen, Axel S. Lexmond, Othmane Fourtassi · 2021 · medRxiv
  33. Longitudinal SARS-CoV-2 seroprevalence in Portugal and antibody maintenance 12 months after the start of the COVID-19 pandemic
    Luísa Canto e Castro, Andréia Gomes, Marta Serrano, Ana Helena Guia Pereira, Rita Ribeiro, Patrícia Napoleão, Inês Domingues, Cláudia Silva, Júlia Fanczal, Ângela Afonso et al. · 2021 · Research Square
  34. Immunogenicity of the mRNA-1273 Vaccine in the Phase 3 COVE Trial
    Hana M. El Sahly, Lindsey Robert Baden, Brandon J. Essink, David C. Montefiori, Adrian McDermont, Richard E. Rupp, Michael Lewis, Shobha Swaminathan, Carl Griffin, Veronica G. Fragoso et al. · 2021 · SSRN Electronic Journal
  35. Evidence For COVID-19 Vaccine Deferred Dose 2 Boost Timing
    David E Epperly · 2021 · SSRN Electronic Journal
  36. Immunogenicity of BNT162b2 mRNA-Based Vaccine against SARS-CoV-2 in People with Cystic Fibrosis
    Gianfranco Alicandro, Valeria Daccò, Lisa Cariani, Chiara Rosazza, Calogero Sathya Sciarrabba, Federica Ferraro, Chiara Lanfranchi, Paola Medino, Daniela Girelli, Carla Colombo · 2022 · Preprints.org
  37. Transient Expression in HEK-293 Cells in Suspension Culture as a Rapid and Powerful Tool: SARS-CoV-2 N and Chimeric SARS-CoV-2N-CD154 Proteins as a Case Study
    Thailin Lao, Omar Farnós, Alexi Bueno-Soler, Anays Alvarez, Elsa Rodríguez Rodríguez, Julio Palacios, Kathya Rashida de la Luz, Amine Kamen, Yamila Carpio, Mario Pablo Estrada · 2023 · Biomedicines
  38. A Population-Based Study of SARS-CoV-2 IgG Antibody Responses to Vaccination in Manitoba
    Brielle Martens, Paul G. Van Caeseele, Jared Bullard, Carla Loeppky, Yichun Wei, Joss Reimer, Lyle R. McKinnon, Souradet Y. Shaw, Jason Kindrachuk, Derek Riley Stein · 2024 · Vaccines
  39. Humoral and Cellular Immune Responses to SARS-CoV-2 in Participants with Head and Neck Cancer
    Luminita Gabriela Marutescu, Alexandru Gabriel Enea, Nefeli-Maria Antoniadis, Marian Neculae, Diana-Antonia Costea, Marcela Popa, Elena Dragu, Elena Codrici, Violeta Ristoiu, Bianca Gălățeanu et al. · 2025 · Viruses
  40. Immune Response to COVID-19
    Ricardo Wesley Alberca · 2021 · IntechOpen eBooks
  41. Evaluation of humoral immune responses, effective factors on responses and re-infection in recovered COVID-19 patients
    Majid Asadi-Samani, Marziyeh Soltani, Dhiya Altememy, Fatemeh Imani, Mohammad-Taghi Moradi, Soleiman Kheiri, Fatemeh Asadi-Samani · 2022 · Immunopathologia Persa
  42. Neutralizing antibody creation technologies: case of SARS-CoV-2
    Vladimir P. Baklaushev, Ekaterina M. Samoilova, SM Kuznetsova, Е.В. Ермолаева, Gaukhar M. Yusubalieva, Кальсин Владимир Анатольевич, Anastasiya V. Lipatova, A.V. Troitsky · 2022 · Medicine of Extreme Situations
  43. ASSESSMENT OF SARS-COV-2 SPECIFIC B-CELL IMMUNE MEMORY: EVIDENCE FOR PERSISTENCE UP TO 1 YEAR POST-INFECTION
    Martina Bozhkova, Teodora Kalfova, Steliyan Petrov, Tanya Velyanova, Hristo B. Taskov, Maria H. Nikolova, Marianna Murdjeva · 2023 · PROBLEMS of Infectious and Parasitic Diseases
  44. Immune monitoring of SARS-CoV-2-specific T cell and B cell responses in patients with multiple sclerosis treated with ocrelizumab
    Elina Groß-Albenhausen, Alicia Weier, Markus Velten, Thorsten Heider, Rittika Chunder, Stefanie Küerten · 2023 · Frontiers in Immunology
  45. Evaluation of the Abdala Vaccine: Antibody and Cellular Response to the RBD Domain of SARS-CoV-2
    Lorenzo Islas-Vázquez, Yan Carlos Alvarado-Alvarado, Marisa Cruz‐Aguilar, Henry Velázquez-Soto, Eduardo Villalobos-Gonzalez, Gloria Ornelas-Hall, Sonia Mayra Pérez‐Tapia, María del Carmen Jiménez Martínez · 2023 · Vaccines
  46. Isolation of Rare Antigen-Specific Memory B Cells via Antigen Tetramers
    Lauren Immink, Jenna J. Guthmiller · 2024 · Methods in molecular biology
  47. Dynamic SARS-CoV-2-specific B-cell and T-cell responses induced in people living with HIV after a full course of inactivated SARS-CoV-2 vaccine
    Xiuwen Wang, Xiaodong Yang, Xin Zhang, Hongxia Yan, Junyan Jin, Zhenglai Ma, Junyi Duan, Guanghui Zhang, Tao Huang, Yongzheng Li et al. · 2025 · Frontiers in Immunology
  48. Immunologisch relevante Aspekte der neuen COVID-19-Impfstoffe
    Eva Untersmayr, Elisabeth Förster‐Waldl, Michael Markus Bonelli, Kaan Boztuǧ, Patrick Manfred Brunner, Thomas Eiwegger, Kathrin Eller, Lisa Göschl, Katharina Grabmeier‐Pfistershammer, Wolfram Hötzenecker et al. · 2021 · Allergo Journal
  49. SARS-CoV-2 nucleocapsid protein: Importance in viral infection
    H. M. Shifa ul Haq, Arnaud John Kombe Kombe, Ayesha Zahid, Momal Babar, Weihong Zeng, Hongliang He, Tengchuan Jin · 2022 · JUSTC
  50. Pandemic’s silver lining
    F. Ferrara, S. D'Angelo, M. F. Erasmus, Andre A. R. Teixeira, Camila Leal-Lopes, L. P. Spector, Tom Pohl, A. Fanni, S. Cocklin, A. Bradbury · 2022 · mAbs
  51. Neutralising reactivity against SARS-CoV-2 B.1.617.2 (Delta) variant by vaccination status and pre-exposure
    Enrico Lavezzo, Monia Pacenti, Laura Manuto, Caterina Boldrin, Margherita Cattai, Marco Grazioli, Federico Bianca, Margherita Sartori, Federico Caldart, Gioele Castelli et al. · 2021 · Research Square
  52. Persistence and baseline determinants of seropositivity and reinfection rates in health care workers up to 12.5 months after COVID-19
    Carlota Dobaño, Anna Ramirez, Selena Alonso, Josep Vidal‐Alaball, Gemma Ruiz‐Olalla, Marta Vidal, Rocío Rubio, Emma Cascant, Daniel Parras, Natalia Rodrigo Melero et al. · 2021 · Research Square
  53. Bivalent COVID-19 vaccines boost the capacity of pre-existing SARS-CoV-2-specific memory B cells to cross-recognize Omicron subvariants
    Holly A. Fryer, Daryl Geers, Lennert Gommers, Luca M. Zaeck, Ngoc H. Tan, Bernadette Jones, Abraham Goorhuis, Douwe F. Postma, Leo G. Visser, Philip Mark Hogarth et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  54. Third dose COVID-19 vaccination elicits immune memory in patients with inborn errors of immunity even in absence of neutralizing antibodies
    Emily S.J. Edwards, Raffi Gugasyan, Nirupama P. Varese, Shir Sun, Jessica E. Canning, Ebony G. Blight, Pei Mun Aui, Irene Boo, Stuart Grant Turville, Anupriya Aggarwal et al. · 2025 · medRxiv
  55. Persistence of immunoglobulin G after natural infection with SARS-CoV-2
    Nina Kreuzberger, Caroline Hirsch, Kanika Vanshylla, Veronica Di Cristanziano, Elena Dorando, Zahra Khosravi, Miriam Neidhardt, Susanne Salomon, Ina Monsef, Berit Lange et al. · 2021 · Cochrane Database of Systematic Reviews
  56. Guide pratique à l’intention des laboratoires cliniques pour les tests de sérologie du SRAS-CoV-2
    au nom du groupe de travail sur la sérologie du Réseau des laboratoires de santé publique du Canada (RLSPC), Carmen L. Charlton, Jamil Kanj, Vanessa Tran, Julianne V. Kus, Jonathan B. Gubbay, Carla Osiowy, Jason Lorne Robinson, Inna Sekirov, MICHAEL A. DREBOT et al. · 2021 · Relevé des maladies transmissibles au Canada
  57. Longitudinal observation of antibody responses after SARS-CoV-2 infection at 14 months
    A. Zaidi, P. Dehgani-Mobaraki, N. Yadav, A. Floridi · 2021 · Research Square
  58. Comparative Analysis of SARS-CoV-2-Specific B Cell and Humoral Responses Elicited by Sputnik V in Naïve and COVID-19-Recovered Vaccine Recipients
    Maria G. Byazrova, Sergey V. Kulemzin, Ekaterina A. Astakhova, Беловежец Татьяна Николаевна, Grigory Aleksandrovich Efimov, Anton N. Chikaev, Ilya O. Kolotygin, Andrey A. Gorchakov, Alexander V. Taranin, Alexander V. Filatov · 2021 · SSRN Electronic Journal
  59. RESPONSES OF THE ADAPTIVE SYSTEM OF IMMUNITY TO SARS-COV-2
    Cygankov A.M., V. V. Yanchenko · 2021
  60. COVID-19 variants, available treatments, and vaccinations: An overview study
    Ali Haider Mohammed, Azyyati Mohd Suhaimi, Bassam Abdul Rasool Hassan · 2021 · Al-Rafidain Journal of Medical Sciences
  61. 真情 爱心——记新疆奎屯市金波园社区残疾人协会
    陈丽梅 · 2006 · 中国残疾人
  62. Gary Nash: Preeminent Scholar and Committed Educator
    Linda Symcox · 2009 · The History Teacher
  63. Peer Review #1 of "EpiCurator: an immunoinformatic workflow to predict and prioritize SARS-CoV-2 epitopes (v0.1)"
    2021 · PeerJ
  64. Peer Review #3 of "EpiCurator: an immunoinformatic workflow to predict and prioritize SARS-CoV-2 epitopes (v0.1)"
    2021 · PeerJ
  65. Peer Review #1 of "EpiCurator: an immunoinformatic workflow to predict and prioritize SARS-CoV-2 epitopes (v0.2)"
    2021 · PeerJ
  66. Peer Review #2 of "EpiCurator: an immunoinformatic workflow to predict and prioritize SARS-CoV-2 epitopes (v0.1)"
    2021 · PeerJ
  67. Review 2: "Durable SARS-CoV-2 B cell immunity after mild or severe disease"
    Mark Y. Sangster · 2021
  68. COVID-19, la communication politique et la santé publique : point de vue de l’Analyse Transactionnelle
    Marco Mazzetti, François Vergonjeanne · 2022 · Actualités en analyse transactionnelle/Actualités en analyse transactionnelle
  69. Double-dose mRNA vaccination to SARS-CoV-2 progressively increases recognition of variants-of-concern by Spike RBD-specific memory B cells
    Gemma E. Hartley, Emily S.J. Edwards, Nirupama P. Varese, Irene Boo, Pei Mun Aui, Scott J. Bornheimer, Philip Mark Hogarth, Heidi E. Drummer, Robyn E. O’Hehir, Menno C. van Zelm · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  70. The Advantage Efficacy of Intranasal Live-Attenuated Vaccine Against SARS-CoV-2
    Ratthaphum Sae-ngow · 2022 · International Journal of Science and Healthcare Research
  71. Determining SARS-CoV-2 non-infectivity state–A brief overview
    Siggeir Fannar Brynjolfsson, Hildur Sigurgrímsdóttir, Ólafur Guðlaugsson, Már Kristjánsson, Karl Gustaf Kristinsson, Bjorn Runar Ludviksson · 2022 · Frontiers in Public Health
  72. Elevated Levels of Anti-SARS-Cov2 IgG Antibody in Health Care Workers in Hospitals From Hamadan Province, Iran: A Prospective Study
    Ebrahim Jalili, Saeid Bashirian, Mohammad Reza Faryabi, Mina Noroozbeygi, Ebrahim Daneshyar, Samereh Ghelichkhani, Salman Khazaei, Ghasem Solgi · 2022 · Avicenna Journal of Clinical Microbiology and Infection
  73. Research Article SARS-CoV-2 genetic and immunology insights: what does the scientific community know so far?
    M. Cabrera, Marcela Salazar-Viedma, Vivían D’Afonseca · 2022 · Genetics and Molecular Research
  74. Emerging Pandemic Infectious Disease Threats
    David Brian Corry, Peter Jay Hotez, María Elena Bottazzi, Jill E. Weatherhead, Anthony William Maresso, Emmaline Heckmann, Lynn H. Bimler · 2023 · Elsevier eBooks
  75. Immunoglobulin G follow-up and immune response longevity analysis in SARS-CoV-2 convalescent patients and vaccinated individuals: A longitudinal analysis
    Fadia Mothafar Maki, Anima Namma AL-Thwani, Kareem Shahal Jiad, Karar Nadhum Jawad Musafer · 2023 · Human Antibodies
  76. Improving SARS-CoV-2 variants monitoring in the absence of genomic surveillance capabilities: a serological study in Bolivian blood donors in October 2021 and June 2022
    Lucia Inchauste, Elif Nurtop, Lissete Bautista Machicado, Yanine Leigue Roth, Shirley Lenz Gonzales, Maria Luisa Herrera, Katty Mina Villafan, Pedro Mamani Mamani, Marcelo Ramos Espinoza, Juan Carlos Pavel Suarez et al. · 2025 · eLife
  77. Dynamics and functional characteristics of antibodies and memory B cells to SARS-CoV-2 in peripheral blood from COVID-19 patients for up to 16 months
    Ivan S. Vladimirov, A.S. Zhdanova, Ekaterina Bolashova, Vladimir E. Mukhin, Valentin Vladimirovich Makarov, Vladimir Sergeevich Yudin, Краевой Сергей Александрович · 2023 · Immunologiya
  78. Improving SARS-CoV-2 variants monitoring in the absence of genomic surveillance capabilities: a serological study in Bolivian blood donors in October 2021 and June 2022
    Lucia Inchauste, Elif Nurtop, Lissete Bautista Machicado, Yanine Leigue Roth, Shirley Lenz Gonzales, Maria Luisa Herrera, Katty Mina Villafan, Pedro Mamani Mamani, Marcelo Ramos Espinoza, Juan Carlos Pavel Suarez et al. · 2024 · eLife
  79. Antibody Response against SARS-CoV-2 after mRNA Vaccine in a Cohort of Hospital Healthy Workers Followed for 17 Months
    Domenico Tripodi, Roberto Dominici, Davide Sacco, Claudia Pozzobon, Simona Spiti, Rosanna Falbo, Paolo Brambilla, Paolo Mascagni, Valerio Leoni · 2024 · Vaccines
  80. ОСОБЛИВОСТІ ІМУНІТЕТУ ХВОРИХ НА СЕЧОКАМ’ЯНУ ХВОРОБУ ПІСЛЯ ПЕРЕНЕСЕНОГО COVID-19
    V. Driyanska, Tetyana Poroshina, Oleksandr Vozianov, Rostyslav Ladniuk, Н. А. Калініна, В. Й. Савчук, Н. І. Желтовська, Nataliia Sevastianova, Lawrence M. DuBuske · 2024 · Immunology and Allergy Science and Practice
  81. Improving SARS-CoV-2 variants monitoring in the absence of genomic surveillance capabilities: a serological study in Bolivian blood donors in October 2021 and June 2022
    Lucia Inchauste, Elif Nurtop, Lissete Bautista Machicado, Yanine Leigue Roth, Shirley Lenz Gonzales, Maria Luisa Herrera, Katty Mina Villafan, Pedro Mamani Mamani, Marcelo Ramos Espinoza, Juan Carlos Pavel Suarez et al. · 2025 · eLife
  82. Two gaps to fill for the 2021-2022 winter wave of COVID-19 cases
    Maciej F. Boni · 2021
  83. Impact of baseline humoral immunity on treatment outcomes with molnupiravir in the MOVe-OUT randomized, controlled trial
    Matthew G. Johnson, Julie Strizki, David W. Hilbert, Ying Zhang, Patricia Carmelitano, Michelle L. Hoffman Brown, Dominik J. Wolf, Amanda A. Paschke, Carisa S. De Anda · 2025 · Virology
  84. Additional file 1 of Dynamic changes of functional fitness, antibodies to SARS-CoV-2 and immunological indicators within 1 year after discharge in Chinese health care workers with severe COVID-19: a cohort study
    Xiong, Lijuan, Li, Qian, Cao, Xiongjing, Xiong, Huangguo, Huang, Ming, Yang, Fengwen, Liu, Qingquan, Daquan Meng, Zhou, Mei, Wang, Gang et al. · 2021 · Figshare
  85. Additional file 1 of Sustained seropositivity up to 20.5 months after COVID-19
    Carlota Dobaño, Ramírez-Morros, Anna, Selena Alonso, Rocío Rubio, Gemma Ruiz‐Olalla, Vidal-Alaball, Josep, Dídac Macià, Queralt Miró Catalina, Marta Vidal, Casanovas, Aina Fuster et al. · 2022 · Figshare
  86. Additional file 1 of Neutralising reactivity against SARS-CoV-2 Delta and Omicron variants by vaccination and infection history
    Enrico Lavezzo, Monia Pacenti, Laura Manuto, Caterina Boldrin, Margherita Cattai, Marco Grazioli, Federico Bianca, Margherita Sartori, Federico Caldart, Gioele Castelli et al. · 2022 · Figshare
  87. Additional file 1 of Changing patterns of SARS-CoV-2 infection through Delta and Omicron waves by vaccination status, previous infection and neighbourhood deprivation: a cohort analysis of 2.7 M people
    Mark Alan Green, Daniel Hungerford, David Michael Hughes, Garcia-Fiñana, Marta, Turtle, Lance, Christopher Paul Cheyne, Matthew Ashton, Gary Leeming, Malcolm Gracie Semple, Alex David Singleton et al. · 2022 · Figshare
  88. Age-dependent immune profiles and variant-driven humoral alterations across two SARS-CoV-2 epidemic phases
    Mingyan Dai, Nana Guo, Yajing Wu, Shiyou Liu, Guangyue Han, Xu Han, Q J Li · 2026 · Frontiers in Immunology
  89. Caractérisation des activités antivirales des anticorps anti-VIH-1 et anti-SARS-CoV-2
    Jérémy Dufloo · 2021 · theses.fr (ABES)
  90. Caractérisation de la réponse lymphocytaire B mémoire contre le SARS-CoV-2 après infection ou vaccination
    Aurélien Sokal · 2022 · theses.fr (ABES)
  91. Étude de la réponse humorale lors de l'infection par le SARS-CoV-2
    Stéphane Marot · 2023 · theses.fr (ABES)
  92. Biphasic Effects on Allergen‐Specific Type 2 Memory B Cells Over 18 Months Sublingual Immunotherapy for House Dust Mite Allergy
    Lin Hsin, Simone Reinwald, Anouk von Borstel, Pei Mun Aui, Kirsten Deckert, Philip Mark Hogarth, Laurent Mascarell, Mark J Hew, Robyn E. O’Hehir, Menno C. van Zelm · 2026 · Allergy
  93. Humoral and cellular responses to SARS‐CoV‐2 variants after ancestral COVID‐19 vaccines in people with HIV and lung transplant recipients
    David W J Griffin, Paul A. Gill, Irene Boo, Shir Sun, Raffi Gugasyan, Alina Wang, Scott J. Bornheimer, Stuart Grant Turville, Anupriya Aggarwal, Greg I Snell et al. · 2026 · Clinical & Translational Immunology
  94. Differential functional immune recall across homologous and heterologous COVID-19 vaccination regimens
    Naim Che-Kamaruddin, Jefree Johari, Hasmawati Yahaya, Nurhafiza Zainal, Huy C Nguyen, Robert D. Hontz, Andrew G. Letizia, Sazaly AbuBakar · 2026 · Frontiers in Immunology
  95. Impaired memory B-cell formation after mRNA-based COVID-19 booster vaccination in patients with inflammatory bowel disease receiving anti-TNF treatment
    Paul A. Gill, Lachlan R. Bradbury, Alina Wang, Julie Hogg, Kathryn Demase, Jo McKenzie, Holly A. Fryer, Daryl Geers, Luca M. Zaeck, Irene Boo et al. · 2026 · medRxiv